We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The indication for the treatment of post-operative pain has been removed from the licences of all prolonged release opioids due to the increased risk of persistent post-operative opioid use (PPOU) and opioid-induced ventilatory impairment (OIVI).
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
Updated product information and packaging will help patients better understand the risks of dependency, addiction, and withdrawal with these medicines.
List of words and phrases that will cause a veterinary product to be medicinal by presentation either through use or contextual use.
There are currently 2 recognised viruses that cause haemorrhagic fever illnesses in Bolivia that are classed as high consequence infectious diseases (HCIDs). These are Machupo virus (MACV) and Chapare virus (CHAPV).
Insufficient pain management is common in disaster settings, and regional anesthesia has the potential to reduce pain in injured patients
The prohibitions and restrictions on the import of animal furs and skins into the UK and the export of salmon and trout.
Lassa virus causes Lassa fever, an acute viral haemorrhagic fever (VHF).
Guiding principles for the use of predetermined change control plans (PCCPs) for managing rapid product changes in medical devices.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).